- Home
- AGS vs CRVS Comparison
AGS vs CRVS Comparison
Compare AGS & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGS
- CRVS
- Stock Information
- Founded
- AGS 2005
- CRVS 2014
- Country
- AGS United States
- CRVS United States
- Employees
- AGS N/A
- CRVS N/A
- Industry
- AGS Miscellaneous manufacturing industries
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- AGS Consumer Discretionary
- CRVS Health Care
- Exchange
- AGS Nasdaq
- CRVS Nasdaq
- Market Cap
- AGS 455.5M
- CRVS 451.0M
- IPO Year
- AGS 2018
- CRVS 2016
- Fundamental
- Price
- AGS $11.63
- CRVS $8.19
- Analyst Decision
- AGS Hold
- CRVS Buy
- Analyst Count
- AGS 4
- CRVS 4
- Target Price
- AGS $12.63
- CRVS $12.83
- AVG Volume (30 Days)
- AGS 180.5K
- CRVS 1.1M
- Earning Date
- AGS 11-07-2024
- CRVS 11-12-2024
- Dividend Yield
- AGS N/A
- CRVS N/A
- EPS Growth
- AGS 150.52
- CRVS N/A
- EPS
- AGS 0.17
- CRVS N/A
- Revenue
- AGS $386,033,000.00
- CRVS N/A
- Revenue This Year
- AGS $10.08
- CRVS N/A
- Revenue Next Year
- AGS $4.97
- CRVS N/A
- P/E Ratio
- AGS $68.45
- CRVS N/A
- Revenue Growth
- AGS 12.18
- CRVS N/A
- 52 Week Low
- AGS $7.11
- CRVS $1.30
- 52 Week High
- AGS $11.75
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- AGS 55.90
- CRVS 51.74
- Support Level
- AGS $11.60
- CRVS $8.67
- Resistance Level
- AGS $11.71
- CRVS $10.00
- Average True Range (ATR)
- AGS 0.04
- CRVS 0.84
- MACD
- AGS -0.01
- CRVS -0.18
- Stochastic Oscillator
- AGS 27.27
- CRVS 18.10
About AGS PlayAGS Inc.
PlayAGS Inc is a designer and supplier of gaming products and services for the gaming industry. The company mainly supplies electronic gaming machines (EGM), server-based systems and back-office systems which are used by casinos, and various gaming locations. Its operating segments are EGM, Table Products, and Interactive. The EGM segment offers a selection of video slot titles developed for the world-wide marketplace as well as EGM cabinets. Its Table Products segments include live proprietary table games and side bets, as well as ancillary table products. The Interactive segment consists of delivering games through mobile apps such as Lucky Play Casino and Vegas Fever. It earns a majority of its revenue from Electronic Gaming Machines segment and geographically from the United States.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).